RadNet will acquire Gleamer for up to $270 million, aiming to make DeepHealth the largest global provider of radiology clinical AI solutions.
Key Details
- 1RadNet acquires Paris-based AI firm Gleamer for up to $270 million.
- 2Gleamer serves over 700 customers across 44 countries, with FDA-cleared solutions for musculoskeletal, breast, lung, and brain imaging.
- 3The combined entity aims to become the largest provider of radiology clinical AI solutions globally.
- 4Gleamer's portfolio spans X-ray, mammography, CT, and MRI, and its products have analyzed over 30 million exams at more than 2,250 locations.
- 5Gleamer is expected to reach $30 million in annual recurring revenue in 2024, with compound annual growth over 90% from 2022–2025.
Why It Matters
This acquisition positions RadNet and its DeepHealth subsidiary as a leader in AI-driven radiology, further driving consolidation and innovation in imaging AI. The move underscores the growing demand for robust, FDA-cleared AI solutions across multiple imaging modalities.
Source
Radiology Business
Related News
•AuntMinnie
Deep Learning Model Predicts Brain Tumor MRI Enhancement Without Gadolinium
German researchers developed a deep learning approach to predict MRI contrast enhancement in brain tumors without the need for gadolinium-based agents.
•Radiology Business
Study Highlights Limitations of AI in Prostate MRI Screening
New research points to several shortcomings in implementing AI for MRI-based prostate cancer screening.
•Radiology Business
SimonMed Imaging Introduces Paid AI Add-Ons for Routine Exams
SimonMed Imaging is launching new AI-powered elective services for routine imaging exams with additional out-of-pocket costs for patients.